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Abstract Objective: Experimental
models show that apolipoprotein
CI (apoCI) binds and enhances the
inﬂammatory response to endotoxin.
We studied in patients undergoing
cardiopulmonary bypass surgery
(CPB) and experiencing endotoxemia
during reperfusion whether plasma
apoCI levels correlate with the inﬂam-
matory response and perioperative
cytokine release. Design: Prospec-
tive, observational, clinical cohort
study. Setting: Operating room
(OR) and intensive care unit (ICU)
of a university hospital. Patients:
One hundred ﬁfty-nine consecutive
patients> 18years of age (66% males
(n =105), median age 65 and 67years
for males and females, respectively)
undergoing elective cardiothoracic
surgery with cardiopulmonarybypass.
Interventions: None. Measurements:
Baseline apoCI, apoCIII, total choles-
terol and triglyceride levels, and
perioperative endotoxin and TNF-α
levels were determined. Results:
High preoperative plasma apoCI, but
not apoCIII, levels were associated
(p <0.05) with increased periop-
erative levels of TNF-α in patients
experiencing endotoxemia. This asso-
ciation was not observed in patients
without endotoxemia. Conclusion:
High plasma apoCI is positively
related to proinﬂammatory response
in patients experiencing endotoxemia
and conﬁrms the observations in
animal models.
Keywords Cardiopulmonarybypass ·
SIRS · Endotoxemia · Endotoxin ·
ApoCI · TNF-α
Introduction
The host response to bacterial invasion requires recogni-
tion of pathogens. In Gram-negative bacterial infection,
endotoxin (lipopolysaccharide, LPS), a component of the
Gram-negative bacterial cell wall, is a powerful stimulator
of the host inﬂammatory reaction. Endotoxin elicits this
response by binding to a cell surface receptor composed
of at least three distinct proteins—CD14, Toll-like recep-
tor-4(TLR4)andMD-2[1,2]—andtriggersreleaseofpro-
inﬂammatory cytokines like TNF-α.
We and others have shown that apolipoproteins mod-
ulate the host inﬂammatory response to endotoxin [3].
Functionally, apolipoproteins are surface proteins on cir-
culating lipoprotein particles and regulate the metabolism
and trafﬁcking of these particles. Experimental studies
have shown that apolipoproteins are involved in the
modulation of inﬂammatory processes and protection
against infections agents [4–9]. Recently, we showed
that apolipoprotein CI (apoCI) binds to endotoxin and
stimulates the endotoxin-induced inﬂammatory response
by macrophages in vitro and in vivo in mice [10, 11].1493
The apoCI-mediated enhanced anti-bacterial attack was
essential to protect mice against mortality from Gram-
negative bacterial sepsis. ApoCIII, which is structurally
closely related to apoCI and has a similar distribution over
lipoproteins, did not appear to bind endotoxin and did not
alter the endotoxin-induced inﬂammatory response [10].
These experimental ﬁndings were further supported by
a study in elderly in which high plasma apoCI levels
are associated with a lower risk of mortality from infec-
tion [12, 13]; however, the relation between plasma levels
of apoCI and the inﬂammatory response to endotoxemia
in humans has not been studied systematically.
Cardiac surgery with cardiopulmonary bypass (CPB)
induces a variable systemic inﬂammatory response that
may progress from a relatively mild to a severe and
potentially life-threatening situation [14]. Previously,
we demonstrated an association between the occurrence
of perioperative endotoxemia and the postoperative in-
ﬂammatory response, suggesting endotoxin as etiologic
factor in the cytokine release in patients undergoing
CPB [15]. Splanchnic ischemia and gut reperfusion injury
occurs frequently during the procedure and subsequent
disturbance in gut barrier function, marked by transloca-
tion of endotoxin to the systemic circulation, has been
documented [14, 16, 17].
We postulate that apoCI is a signiﬁcant determinant
of the endotoxin-induced inﬂammatory response in these
patients and assessed the relation between preoperative
apoCI plasma levels and the perioperative cytokine acti-
vation in patients experiencing endotoxemia. To indicate
that a potential relation between apoCI and TNF-α is
not merely a reﬂection of lipid or apolipoprotein levels,
we compare our ﬁndings with those on total cholesterol,
triglycerides and apoCIII.
Materials and methods
The study was performed at the Leiden University Med-
ical Center, an 800-bed secondary and tertiary referral
hospital. To be eligible for enrolment, patients had to be
aged 18 years or older and being scheduled for elective
cardiac surgery with cardiopulmonary bypass between
1 July 1998 and 30 December 1999. We obtained institu-
tional approval from the local medical ethics committee
(protocol no. P168/96). Each patient gave a written,
informed consent. One hundred ﬁfty-nine consecutive
patients undergoing elective cardiac surgery with CPB
were studied, which has been extensively described
previously [18, 19].
Sample collection
Brieﬂy, blood samples were collected from each patient
before anaesthetic induction (time point 1), on aorta
declamping (time point 2), 30min into body reperfusion
(i.e. 30min after termination of extra corporal perfusion,
time point 3), and at ICU admission (approximately 2h
after surgery, time point 4) [18, 19].
Endotoxin and TNF-alpha measurements
Blood for endotoxin determination was collected in
pyrogen-free tubes and platelet-rich plasma was prepared
by centrifugation. Endotoxin was determined by a quan-
titative photometric assay with end-point measurement.
The assay’s lower detection limit for endotoxin was
3.0pg/ml [20]. Endotoxin concentrations≥5pg/ml were
considered to indicate endotoxemia [20, 21]. Blood for
determination of TNF-a was collected in pyrogen-free
ethylenediaminetetraacetic acid (EDTA) tubes and im-
mersed in ice. Plasma was prepared by centrifugation at
3000g for 5–10min at 4°C and stored at –70°C. Tumor
necrosis factor (TNF)-α concentrations were determined
with a standard ELISA technique. The lower detection
limit for TNF-α was 0.1pg/ml [18, 19].
Plasma total cholesterol, triglycerides and apolipoprotein
measurements
Plasma apoCI andapoCIII levels were assayedusingsand-
wich ELISAs speciﬁc for human apoCI [13] and apoC-
III [22], as described. For both ELISAs the inter-assay
coefﬁcient of variance is typically less than 10%, while the
intra-assay coefﬁcient of variance is typically less than 7%
(apoCI) and 5% (apoCIII). No cross-reactivity of the used
antibodies is observed with other apolipoproteins. Total
cholesterol and triglycerides levels were determined using
commercially available kits (Roche Diagnostics Choles-
terol Reagent and Triglyceride Reagent, respectively;
Roche Diagnostics, Almere, The Netherlands).
Analysis of data
Correlations were assessed non-parametrically using
Spearman correlation test, comparisons between groups
were made using Kruskal–Wallis test, individual groups
were compared by the Mann–Whitney U-test, unless
indicated otherwise. Statistical signiﬁcance was tested two
tailed, with α set at 0.05.
Results
Patient characteristics
We studied 159 consecutive patients undergoing elective
cardiothoracic surgery with CPB. The patient charac-1494
teristics have been described previously [18]. Surgical
procedures were extensive; 19 patients (12%) underwent
coronary artery bypass surgery (CABG) combined with
valve replacement, 87 patients (55%) underwent CABG
only and 48 patients (30%) underwent valve replacement
only(Table1). Fivepatients(3%)underwentothersurgical
procedures, mainly aortic surgery (Table1).
Correlation between preoperative cholesterol, triglyceride,
apoCI and apoCIII levels and perioperative TNF-alpha
release
Data on cholesterol, triglycerides, apoCI and apoCIII were
available for 148 patients. Perioperative TNF-α levels
were available for 112, 106, 108 and 110 patients for time
points 1, 2, 3 and 4, respectively.Endotoxin levels for time
points 2 and/or 3 were available for 143 patients.
The relationship between perioperative endotoxemia
and cytokine release in these 159 patients has been
described previously [18, 19]. Brieﬂy, we found that
perioperative endotoxemia was positively correlated
with subsequent TNF-α release. In the current analysis
we assessed correlations between preoperative plasma
levels of cholesterol, triglyceride, apoCI and apoCIII with
perioperative TNF-α plasma concentrations.
In patients with signiﬁcant endotoxemia (endotoxin
level≥5pg/ml at time points 2 and/or 3; n=85) we
observed a signiﬁcant correlation between preoperative
apoCI and cholesterol levels and TNF-α concentrations
at time points 2–4 (the latter for apoCI only), whereas
no such correlation could be observed with preoperative
apoCIII and triglyceride levels (Table2). No signiﬁcant
correlations were observed in patients without endotox-
emia as deﬁned by an endotoxin level< 5pg/ml at both
time points 2 and 3 (n =58; Table2).
To visualize the apoCI data we split the endotoxemia-
positive and endotoxemia-negative patients into three
Variables Time point 2 Time point 3 Time point 4
Endotoxemia positive n=63 n=65 n=65
Cholesterol 0.434∗∗∗ 0.259∗ 0.174
Triglycerides 0.133 0.236 0.237
ApoCI 0.305∗ 0.351∗∗ 0.425∗∗∗
ApoCIII −0.106 0.062 0.077
Endotoxemia negative n=36 n=35 n=35
Cholesterol 0.186 0.074 −0.329
Triglycerides 0.214 0.037 −0.153
ApoCI 0.299 0.157 −0.330
ApoCIII −0.161 −0.060 −0.068
∗ p<0.05, ∗∗ p<0.01, ∗∗∗ p<0.001 (Spearman correlation test)
Table 2 Correlation coefﬁcient
between preoperative lipid/
apolipoprotein level and TNF-α
concentration at consecutive
time points perioperatively. Time
points 2–4 correspond with aorta
declamping, 30min into body
reperfusion (i.e. 30min after
termination of extra-corporal
perfusion) and admission to the
ICU (approximately 2h after
surgery), respectively. Signiﬁ-
cant correlations were observed
between cholesterol and TNF-α
in endotoxemia-positive patients
at time points 2 and 3, and
ApoCI and TNF-α in endo-
toxemia-positive patients at time
points 2–4
Table 1 Characteristics of 159 patients undergoing elective cardiac
surgery with cardiopulmonary bypass. CABG, coronary artery by-
pass graft; ICU, intensive care unit; MOF, multiple organ dysfunc-
tion
Variables Values
Preoperative data
Age (years) 65 (56–72)
Weight (kg) 78 (68–88)
Males, n (%) 106 (67)
Active smoker, n (%) 31 (20)
Diabetes (types I and II), n (%) 19 (12)
ASA score, n (%)
≤21 2 ( 8 )
3 88 (55)
≥49 ( 6 )
Unknown 50 (32)
Type of operation
CABG only, n (%) 87 (55)
Valve replacement only, n (%) 48 (30)
CABG and valve replacement, n (%) 19 (12)
Other, n (%) 5 (3)
Perioperative data
Operation time (min) 240 (183–285)
Perfusion time (min) 116 (85–141)
Aorta clamp time (min) 71 (49–90)
Lowest temperature (◦C) 29 (28–31)
Postoperative data
Days on ventilator 1 (1–2)
ICU stay (days) 3 (2–5)
MOF, n (%) 6 (3.8)
Hospital stay (days) 11 (9–15)
Fatalities, n (%) 14 (9)
Median values and interquartile range in parentheses
equally large groups (tertiles) according to their preoper-
ative plasma cholesterol, triglyceride, apoCI and apoCIII
levels (tertiles), and plotted these against the TNF-α con-
centration at the four time points. High preoperativeapoCI
levels were markedly associated with increased TNF-α
concentration at time points 2–4 in endotoxemia-positive1495
Fig.1 Perioperative TNF-α
concentration in patients
experiencing endotoxemia (a)
and those without (b) according
to preoperative apoCI and
apoCIII tertiles (1=lo west
tertile, 2=intermediate tertile,
3=highest tertile). The p-values
were calculated using Kruskal–
Wallis test
patients (Fig.1a), but not in endotoxemia-negativepatients
(Fig. 1b). No associations were found with preoperative
apoCIII levels (Fig. 1).
Discussion
The main ﬁnding of the present study is that in patients
undergoing cardiac surgery with cardiopulmonary bypass
(CPB) high plasma apoCI levels are correlated with an
enhanced proinﬂammatory response in patients experi-
encing endotoxemia as compared with patients without
endotoxemia. This characteristic is not shared among
all apolipoproteins or lipids, since this observation did
not hold for apoCIII or triglyceride levels and TNF-α
levels. Although at some time points a correlation with
cholesterol was found as well, these correlations are less
pronounced and consistent. On the contrary, the proin-
ﬂammatory response in patients without endotoxemia was
not correlated with apoCI levels. This ﬁnding suggests
a role for apoCI in enhancingthe host responseto bacterial
products involved in pathogen recognition.
To our knowledge, this is the ﬁrst study indicating
this relationship between plasma levels of apoCI and the1496
inﬂammatory response to endotoxemia in humans in vivo.
This ﬁnding is relevant for understanding mechanisms
by which the host mounts a swift response to invading
micro-organisms in the early phase of infection. An early
proinﬂammatory cytokine response to invading pathogens
is crucial for containment and elimination of the bacteria,
whereas in a latter phase a high proinﬂammatory response
is often harmful and may lead to tissue damage and organ
failure. In Gram-negative bacterial infection, endotoxin
(LPS) is a powerful stimulator of the host inﬂamma-
tory reaction through activation of the TLR4 signaling
pathway.
Previously, we demonstrated in mice that apoCI binds
to endotoxin and enhances the endotoxin-induced proin-
ﬂammatory response, thereby invigorating host response
mechanisms. Based on our current ﬁndings, apoCI may
also enhance the endotoxin-induced proinﬂammatory re-
sponse in humans. Moreover, combined with our previous
observation that subjects with high plasma apoCI levels
at baseline are less prone to mortality from infection
during a 5-year follow-up [13], these ﬁndings support
a beneﬁcial role for apoCI in the handling of infections in
humans. High plasma apoCI levels may protect against
bacterial invasion by enhancing the proinﬂammatory
response directed towards endotoxin, in line with our
experimental studies.
With respect to this study and methodology, several
issues need to be considered. The cut-off level of endo-
toxin concentration indicating signiﬁcant endotoxemia
is somewhat arbitrary; however, it is based on previous
studies and has been prospectively evaluated [20, 21].
Furthermore, the criterion used is substantiated by our
previous ﬁndings in these patients, in which we observed
signiﬁcantly higher cytokine concentrations in patients
with endotoxemia, according to this criterion, as com-
pared with those without. These clinical data conﬁrm
the rationale to dichotomise the group according to
endotoxemia. In the current study we assessed TNF-α
as measure of the proinﬂammatory cytokine response.
TNF-α plays a central role in the proinﬂammatory cy-
tokine cascade. The ﬁndings would suggest a similar
elevation of other proinﬂammatory cytokines (i.e. IL-6,
IL-1), although we did not measure these mediators here.
An other limitation of our study is that the ﬁndings cannot
be directly extrapolated to patients with Gram-negative
infection: our model is not an infection model in the
sense of live, multiplicating micro-organisms invading the
host. However, naturally occurring endotoxemia mimics
invasive Gram-negative infection and enabled us to study
the in vivo interaction between microbial products and the
host. Furthermore, our study was small, making the power
to detect possible differences in clinical outcome small.
Further prospective studies are now underway to make
these analyses possible.
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